tbuckley/cabot-search huggingface dataset:
Further Considerations Regarding Molecular Screening and Treatment of Bacterial Vaginosis—Reply
Authors: Florence Bretelle, Sandrine Loubière, Florence Fenollar
Journal: JAMA Pediatrics (2023)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Pediatrics HomeNew OnlineCurrent IssueFor Authors Podcast Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Pediatrics journal
Association Between Restricted Abortion Access and Child Entries Into the Foster Care System
Authors: Savannah Adkins, Noa Talmor, Molly H. White, Caryn Dutton, Ashley L. O’Donoghue
Journal: JAMA Pediatrics (2023)

The 2022 US Supreme Court decision Dobbs v Jackson Women's Health Organization overturned federal protections to abortion care, allowing many states to severely restrict or ban access to abortion. Given the implications of the Dobbs ruling, there is a need to understand the full consequences of restricted abortion access. Before 2022, many states restricted access to safe and legal abortions through Targeted Regulation of Abortion Providers (TRAP) laws, which provide a historical mode for estimating the consequences of abortion restrictions.
ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels
Authors: Anna Steward, Davina Biel, Anna Dewenter, Sebastian Roemer, Fabian Wagner, Amir Dehsarvi, Saima Rathore, Diana Otero Svaldi, Ixavier Higgins, Matthias Brendel, Martin Dichgans, Sergey Shcherbinin, Michael Ewers, Nicolai Franzmeier
Journal: JAMA Neurology (2023)

For the Alzheimer disease (AD) therapies to effectively attenuate clinical progression, it may be critical to intervene before the onset of amyloid-associated tau spreading, which drives neurodegeneration and cognitive decline. Time points at which amyloid-associated tau spreading accelerates may depend on individual risk factors, such as apolipoprotein E ε4 (ApoE4) carriership, which is linked to faster disease progression; however, the association of ApoE4 with amyloid-related tau spreading is unclear.
Overnight Stay in the Emergency Department and Mortality in Older Patients
Authors: Melanie Roussel, Dorian Teissandier, Youri Yordanov, Frederic Balen, Marc Noizet, Karim Tazarourte, Ben Bloom, Pierre Catoire, Laurence Berard, Marine Cachanado, Tabassome Simon, Said Laribi, Yonathan Freund, Mathieu Abou-Badra, Sarah Addou, Émilie Allione, Anne-Sophie Bard, Sébastien Beaune, Florian Bernas, Romain Blondet, Anne Bouchara, Alice Boulanger, Arthur Bourg, Claire Broche, Laetitia Cesar, Anthony Chauvin, Alban Chauvineau, Richard Chocron, Tahar Chouihed, Yann Erick Claessens, Pierre Géraud Claret, Julie Contenti, Carole Cornaglia, Valérie Debierre, Marion Douplat, Jonathan Duchenne, Odile Dumont, Romain Durif, Jean Fabre, Anne Laure Feral, Quentin Foubert, Hadrien Friedel, Anne Marie Gangneron, Maxime Gautier, Émilie Gelin, Camille Gerlier, Cédric Gil jardine, Anaïs Girard, Séverine Gosselin, Sylvie Grgek, Magali Guerin, Baroan Bertin Guina, Mélanie Halaoui, Lionel Imsaad, Laure Jainsky, Didier Jammes, Mehdi Khellaf, Melek Sunde Kilic, Gilles Kleiner, Julien Lazar, Pierrick Le Borgne, Adrien Le Brozec, Anne Le Coat, Catherine Le Gall, Sophie Lefebvre, Delphine Levy, Marie Emmanuelle Limoges, Théophile Lormier, Richard Macrez, Anne Mahier, Bastien Malossane, Nicolas Marjanovic, Sylvie Massacrier, Emmanuel Montassier, Benoit Morel, Céline Moretto, Nesrine Nabli, Eloi Nenert, Céline Occelli, Laurent Ortega, Xavier Pereira, Nicolas Persico, Helene Pizzut-Mardegan, Annie Porte, Ludivine Quay, Diana Rafidiniaina, Agnès Ricard-Hibon, Julie Rosenblatt, Dominique Savary, Hugo Schmidt, Bertrand Sorin, Ombeline Susong, Nicolas Termoz Masson, Éric Thibaud, Ayoub Touihar, Jennifer Truchot, Prabakar Vaittinada Ayar, Camille Vennetier, Frederic Verbois, Thibault Viard, Mathias Wargon, Mustapha Youssef, Claude Zamour
Journal: JAMA Internal Medicine (2023)

Patients in the emergency department (ED) who are waiting for hospital admission on a wheeled cot may be subject to harm. However, mortality and morbidity among older patients who spend the night in the ED while waiting for a bed in a medical ward are unknown.
<i>APOE</i> Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry
Authors: Michael E. Belloy, Shea J. Andrews, Yann Le Guen, Michael Cuccaro, Lindsay A. Farrer, Valerio Napolioni, Michael D. Greicius
Journal: JAMA Neurology (2023)

Apolipoprotein E (APOE)*2 and APOE*4 are, respectively, the strongest protective and risk-increasing, common genetic variants for late-onset Alzheimer disease (AD), making APOE status highly relevant toward clinical trial design and AD research broadly. The associations of APOE genotypes with AD are modulated by age, sex, race and ethnicity, and ancestry, but these associations remain unclear, particularly among racial and ethnic groups understudied in the AD and genetics research fields.
<i>APOE</i> Genotype in the Era of Disease-Modifying Treatment With Monoclonal Antibodies Against Amyloid-β
Authors: Rik Ossenkoppele, Wiesje M. van der Flier
Journal: JAMA Neurology (2023)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Neurology HomeNew OnlineCurrent IssueFor Authors Podcast Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Neurology journal
Brexpiprazole for the Treatment of Agitation and Aggression in Alzheimer Disease
Authors: Clive Ballard
Journal: JAMA Neurology (2023)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Neurology HomeNew OnlineCurrent IssueFor Authors Podcast Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Neurology journal
The Natural History of Disability and Caregiving Before and After Long-Term Care Entry
Authors: Kenneth Lam, Irena Cenzer, Cari R Levy, Dan D. Matlock, Alexander K. Smith, Kenneth E. Covinsky
Journal: JAMA Internal Medicine (2023)

Many older persons move into long-term care facilities (LTCFs) due to disability and insufficient home caregiving options. However, the extent of disability and caregiving provided around the time of entry is unknown.
Care Demands Ahead of Transitioning Into Residential Care—A Window Into Family Caregiving at Home
Authors: Chanee D. Fabius, Jennifer L. Wolff, Vicki A. Freedman
Journal: JAMA Internal Medicine (2023)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
The Risks of Being in Limbo in the Emergency Department
Authors: Timothy S. Anderson, Shoshana J. Herzig
Journal: JAMA Internal Medicine (2023)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes
Authors: Steven C. Wall, Naveenchandra Suryadevara, Changil Kim, Andrea R. Shiakolas, Clinton M. Holt, Emma B. Irbe, Perry T. Wasdin, Yukthi P. Suresh, Elad Binshtein, Elaine C. Chen, Seth J. Zost, Elizabeth Canfield, James E. Crowe, Mary Ann Thompson-Arildsen, Daniel J. Sheward, Robert H. Carnahan, Ivelin S. Georgiev
Journal: Cell Reports Medicine (2023)

From the beginning of the COVID-19 pandemic, children have exhibited different susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, reinfection, and disease compared with adults. Motivated by the established significance of SARS-CoV-2-neutralizing antibodies in adults, here we characterize SARS-CoV-2-specific antibody repertoires in a young cohort of individuals aged from 5 months to 18 years old. Our results show that neutralizing antibodies in children possess similar genetic features compared to antibodies identified in adults, with multiple antibodies from children belonging to previously established public antibody clonotypes in adults. Notably, antibodies from children show potent neutralization of circulating SARS-CoV-2 variants that have cumulatively resulted in resistance to virtually all approved monoclonal antibody therapeutics. Our results show that children can rely on similar SARS-CoV-2 antibody neutralization mechanisms compared to adults and are an underutilized source for the discovery of effective antibody therapeutics to counteract the ever-evolving pandemic.
A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma
Authors: Kelly M Hotchkiss, Eugene J Cho, Mustafa Khasraw
Journal: Neuro-Oncology (2023)

Journal Article A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma Get access Kelly M Hotchkiss, Kelly M Hotchkiss The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Eugene J Cho, Eugene J Cho The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Mustafa Khasraw Mustafa Khasraw The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA Corresponding author: Mustafa Khasraw, MD, The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Box 3624, Durham, NC 27710, USA (mustafa.khasraw@duke.edu). https://orcid.org/0000-0003-3249-9849 Search for other works by this author on: Oxford Academic PubMed Google Scholar Neuro-Oncology, Volume 26, Issue 1, January 2024, Pages 5–6, https://doi.org/10.1093/neuonc/noad203 Published: 31 October 2023 Article history Published: 31 October 2023 Corrected and typeset: 09 November 2023
Abortion Restrictions and the Impact on Families
Authors: Tracey A. Wilkinson, Caitlin Bernard
Journal: JAMA Pediatrics (2023)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Pediatrics HomeNew OnlineCurrent IssueFor Authors Podcast Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Pediatrics journal
Stem cell–like reprogramming is required for leukemia-initiating activity in B-ALL
Authors: Vincent Fregona, Manon Bayet, Mathieu Bouttier, Laetitia Largeaud, Camille Hamelle, Laura A. Jamrog, Naïs Prade, Stéphanie Lagarde, Sylvie Hebrard, Isabelle Luquet, Véronique Mansat-De Mas, Marie Nolla, Marlène Pasquet, Christine Didier, Ahmed Amine Khamlichi, Cyril Broccardo, Éric Delabesse, Stéphane J.C. Mancini, Bastien Gerby
Journal: The Journal of Experimental Medicine (2023)

B cell acute lymphoblastic leukemia (B-ALL) is a multistep disease characterized by the hierarchical acquisition of genetic alterations. However, the question of how a primary oncogene reprograms stem cell–like properties in committed B cells and leads to a preneoplastic population remains unclear. Here, we used the PAX5::ELN oncogenic model to demonstrate a causal link between the differentiation blockade, the self-renewal, and the emergence of preleukemic stem cells (pre-LSCs). We show that PAX5::ELN disrupts the differentiation of preleukemic cells by enforcing the IL7r/JAK-STAT pathway. This disruption is associated with the induction of rare and quiescent pre-LSCs that sustain the leukemia-initiating activity, as assessed using the H2B-GFP model. Integration of transcriptomic and chromatin accessibility data reveals that those quiescent pre-LSCs lose B cell identity and reactivate an immature molecular program, reminiscent of human B-ALL chemo-resistant cells. Finally, our transcriptional regulatory network reveals the transcription factor EGR1 as a strong candidate to control quiescence/resistance of PAX5::ELN pre-LSCs as well as of blasts from human B-ALL.
Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?
Authors: Kim N. van Munster, Annika Bergquist, Cyriel Y. Ponsioen
Journal: Journal of Hepatology (2023)

Primary sclerosing cholangitis (PSC) was declared one of the biggest unmet needs in hepatology during International Liver Congress 2016 in Berlin. Since then, not much has changed unfortunately, largely due to the still elusive pathophysiology of the disease. One of the most striking features of PSC is its association with inflammatory bowel disease (IBD), with the majority of patients with PSC being diagnosed with extensive colitis. This review describes the epidemiology of IBD in PSC, its specific phenotype, complications and potential pathophysiological mechanisms connecting the two diseases. Whether PSC is merely an extra-intestinal manifestation of IBD or if PSC and IBD are two distinct diseases that happen to share a common susceptibility that leads to a dual phenotype is debated. Implications for the management of the two diseases together are also discussed. Overall, this review summarises the available data in PSC-IBD and discusses whether PSC and IBD are one or two disease(s).
Active Osteoblasts or Quiescent Bone Lining Cells? Preosteoblasts Fate Orchestrated by Curvature and Stiffness of an In Vitro 2.5D Biomimetic Culture System
Authors: Hélène Ozanne, Loïc Moubri, Léa Abou‐Nassif, Olivier Thoumire, Aline Echalard, Sandrine Morin‐Grognet, Hassan Atmani, Guy Ladam, Béatrice Labat
Journal: Advanced Healthcare Materials (2023)

Biomimetic cell culture systems are required to provide more physiologically relevant microenvironments for bone cells. Here, a simple 2.5D culture platform is proposed, combining adjustable stiffness and surface features that mimic bone topography by using sandpaper grits as master molds with two stiffness formulations of polydimethylsiloxane (PDMS). The subsequent replicas perfectly conform the grits and reproduce the corresponding negative relief with cavities separated by convex edges. Biomimicry is also provided by an extracellular matrix (ECM)-like thin film coating, using the layer-by-layer (LbL) method. The topographical features, alternating concave, and convex structures drive preosteoblasts organization and morphology. Strikingly, curvature orchestrates the commitment of preosteoblasts, with i) maturation to active osteoblasts able to produce a dense collagenous matrix that ultimately mineralizes in the cavities, and ii) edges hosting quiescent cells that synthetize a very thin immature collagen layer with no mineralization. In summary, the present in vitro culture system model offers a cell-instructive 2.5D microenvironment that controls preosteoblasts fate, leading to two coexisting subpopulations: mature osteoblasts and bone lining cells (BLC). This promising culture system opens new avenues to advanced tissue-engineered modeling and can be applied to precellularized bone biomaterials.
Quantification of evolved DNA-editing enzymes at scale with DEQSeq
Authors: Lukas Theo Schmitt, Aksana Schneider, Jonas Posorski, Felix Lansing, Milica Jelicic, Manavi Jain, Shady Sayed, Frank Buchholz, Duran Sürün
Journal: Genome biology (2023)

Abstract We introduce DEQSeq, a nanopore sequencing approach that rationalizes the selection of favorable genome editing enzymes from directed molecular evolution experiments. With the ability to capture full-length sequences, editing efficiencies, and specificities from thousands of evolved enzymes simultaneously, DEQSeq streamlines the process of identifying the most valuable variants for further study and application. We apply DEQSeq to evolved libraries of Cas12f-ABEs and designer-recombinases, identifying variants with improved properties for future applications. Our results demonstrate that DEQSeq is a powerful tool for accelerating enzyme discovery and advancing genome editing research.
Phenotypic and proteomic characterization of the human erythroid progenitor continuum reveal dynamic changes in cell cycle and in metabolic pathways
Authors: Julien Papoin, Hongxia Yan, Marjorie Leduc, Morgane Le Gall, Anupama Narla, James Palis, Laurie A. Steiner, Patrick G. Gallagher, Christopher D. Hillyer, Emilie‐Fleur Gautier, Narla Mohandas, Lionel Blanc
Journal: American Journal of Hematology (2023)

Abstract Human erythropoiesis is a complex process leading to the production of 2.5 million red blood cells per second. Following commitment of hematopoietic stem cells to the erythroid lineage, this process can be divided into three distinct stages: erythroid progenitor differentiation, terminal erythropoiesis, and reticulocyte maturation. We recently resolved the heterogeneity of erythroid progenitors into four different subpopulations termed EP1–EP4. Here, we characterized the growth factor(s) responsiveness of these four progenitor populations in terms of proliferation and differentiation. Using mass spectrometry‐based proteomics on sorted erythroid progenitors, we quantified the absolute expression of ~5500 proteins from EP1 to EP4. Further functional analyses highlighted dynamic changes in cell cycle in these populations with an acceleration of the cell cycle during erythroid progenitor differentiation. The finding that E2F4 expression was increased from EP1 to EP4 is consistent with the noted changes in cell cycle. Finally, our proteomic data suggest that the protein machinery necessary for both oxidative phosphorylation and glycolysis is present in these progenitor cells. Together, our data provide comprehensive insights into growth factor‐dependence of erythroid progenitor proliferation and the proteome of four distinct populations of human erythroid progenitors which will be a useful framework for the study of erythroid disorders.
Growth of the Neo-Aortic Root and Prognosis of Transposition of the Great Arteries
Authors: Aditya Sengupta, Chrystalle Katte Carreon, Kimberlee Gauvreau, Ji M. Lee, Stephen P. Sanders, Steven D. Colan, Pedro J. del Nido, John E. Mayer, Meena Nathan
Journal: Journal of the American College of Cardiology (2023)